Cargando…

Vγ9Vδ2 T Cells Concurrently Kill Cancer Cells and Cross-Present Tumor Antigens

The human Vγ9Vδ2 T cell is a unique cell type that holds great potential in immunotherapy of cancer. In particular, the therapeutic potential of this cell type in adoptive cell therapy (ACT) has gained interest. In this regard optimization of in vitro expansion methods and functional characterizatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Holmen Olofsson, Gitte, Idorn, Manja, Carnaz Simões, Ana Micaela, Aehnlich, Pia, Skadborg, Signe Koggersbøl, Noessner, Elfriede, Debets, Reno, Moser, Bernhard, Met, Özcan, thor Straten, Per
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8208807/ https://www.ncbi.nlm.nih.gov/pubmed/34149689 http://dx.doi.org/10.3389/fimmu.2021.645131

Ejemplares similares

Expansion With IL-15 Increases Cytotoxicity of Vγ9Vδ2 T Cells and Is Associated With Higher Levels of Cytotoxic Molecules and T-bet
por: Aehnlich, Pia, et al.
Publicado: (2020)

Combined killing of cancer cells and cross presentation of tumor antigen by Vγ9Vδ2 T cells
por: Olofsson, Gitte Holmen, et al.
Publicado: (2015)

Chemokine receptor engineering of T cells with CXCR2 improves homing towards subcutaneous human melanomas in xenograft mouse model
por: Idorn, Manja, et al.
Publicado: (2018)

Improved migration of tumor ascites lymphocytes to ovarian cancer microenvironment by CXCR2 transduction
por: Idorn, Manja, et al.
Publicado: (2017)

Genetic engineering of T cells for increased homing to the tumor site
por: Idorn, Manja, et al.
Publicado: (2014)

Adrenergic Signaling in Immunotherapy of Cancer: Friend or Foe?
por: Jensen, Agnete Witness Praest, et al.
Publicado: (2021)

Exercise Oncology and Immuno-Oncology; A (Future) Dynamic Duo
por: Holmen Olofsson, Gitte, et al.
Publicado: (2020)

Exploitation of gamma delta T cells in cancer immunotherapy as combined antigen-presenters and cancer cell killers
por: Holmen Olofsson, Gitte, et al.
Publicado: (2014)

Chemokine Receptors and Exercise to Tackle the Inadequacy of T Cell Homing to the Tumor Site
por: Idorn, Manja, et al.
Publicado: (2018)

Exercise and cancer: from “healthy” to “therapeutic”?
por: Idorn, Manja, et al.
Publicado: (2017)

High frequency of T cells specific for cryptic epitopes in melanoma patients
por: Andersen, Rikke Sick, et al.
Publicado: (2013)

Mitochondrial-Linked De Novo Pyrimidine Biosynthesis Dictates Human T-Cell Proliferation but Not Expression of Effector Molecules
por: Peeters, Marlies J. W., et al.
Publicado: (2021)

P75. Genetic engineering of T cells for increased homing to the tumor site
por: Idorn, M, et al.
Publicado: (2014)

Exercise suppresses tumor growth through epinephrine- and IL-6-dependent mobilization and redistribution of NK cells
por: Pedersen, Line, et al.
Publicado: (2015)

Patients With Myeloproliferative Neoplasms Harbor High Frequencies of CD8 T Cell-Platelet Aggregates Associated With T Cell Suppression
por: Carnaz Simões, Ana Micaela, et al.
Publicado: (2022)

Corrigendum: Patients with myeloproliferative neoplasms harbor high frequencies of CD8 T cell-platelet aggregates associated with T cell suppression
por: Simões, Ana Micaela Carnaz, et al.
Publicado: (2022)

Association of a functional Indoleamine 2,3-dioxygenase 2 genotype with specific immune responses
por: Køllgaard, Tania, et al.
Publicado: (2012)

Pre-Vaccination Frequencies of Th17 Cells Correlate with Vaccine-Induced T-Cell Responses to Survivin-Derived Peptide Epitopes
por: Køllgaard, Tania, et al.
Publicado: (2015)

Clonal expansion of renal cell carcinoma-infiltrating T lymphocytes
por: Sittig, Simone P, et al.
Publicado: (2013)

TAM Receptor Inhibition–Implications for Cancer and the Immune System
por: Aehnlich, Pia, et al.
Publicado: (2021)

DGK-α: A Checkpoint in Cancer-Mediated Immuno-Inhibition and Target for Immunotherapy
por: Noessner, Elfriede
Publicado: (2017)

Small Molecule Inhibitors of MERTK and FLT3 Induce Cell Cycle Arrest in Human CD8(+) T Cells
por: Powell, Richard M., et al.
Publicado: (2021)

Collagen density regulates the activity of tumor-infiltrating T cells
por: Kuczek, Dorota E., et al.
Publicado: (2019)

Analysis of Vδ1 T cells in clinical grade melanoma-infiltrating lymphocytes
por: Donia, Marco, et al.
Publicado: (2012)

Cord Blood Vα24-Vβ11(+) Natural Killer T Cells Display a Th2-Chemokine Receptor Profile and Cytokine Responses
por: Harner, Susanne, et al.
Publicado: (2011)

T cell therapy in combination with Vemurafenib in BRAF mutated metastatic melanoma patients
por: Borch, Troels Holz, et al.
Publicado: (2014)

Broadening the repertoire of melanoma-associated T-cell epitopes
por: Frøsig, Thomas Mørch, et al.
Publicado: (2015)

Checkpoint Inhibition in Bladder Cancer: Clinical Expectations, Current Evidence, and Proposal of Future Strategies Based on a Tumor-Specific Immunobiological Approach
por: Mancini, Mariangela, et al.
Publicado: (2021)

Characterization of SARS‐CoV‐2 humoral immune response in a subject with unique sampling: A case report
por: Walker, Melanie R., et al.
Publicado: (2023)

High Intensity Aerobic exercise training and Immune cell Mobilization in patients with lung cancer (HI AIM)—a randomized controlled trial
por: Holmen Olofsson, Gitte, et al.
Publicado: (2022)

Turning tumor inhibition into activation: engineering T cells with chimeric signaling receptors
por: Schlenker, Ramona, et al.
Publicado: (2014)

Discovery of CD8 T cell epitopes in Merkel cell polyomavirus through combinatorial encoding with MHC multimers
por: Lyngaa, Rikke, et al.
Publicado: (2013)

Hepatocellular carcinoma cell sensitivity to Vγ9Vδ2 T lymphocyte-mediated killing is increased by zoledronate
por: SUGAI, SHIORI, et al.
Publicado: (2016)

Inflammation induced PD-L1-specific T cells
por: Munir, Shamaila, et al.
Publicado: (2019)

Co-Regulation of Immune Checkpoint PD-L1 with Interferon-Gamma Signaling is Associated with a Survival Benefit in Renal Cell Cancer
por: Hänze, Jörg, et al.
Publicado: (2020)

T cell recognition of novel shared breast cancer antigens is frequently observed in peripheral blood of breast cancer patients
por: Viborg, Nadia, et al.
Publicado: (2019)

Combining Vγ9Vδ2 T Cells with a Lipophilic Bisphosphonate Efficiently Kills Activated Hepatic Stellate Cells
por: Zhou, Xiaoying, et al.
Publicado: (2017)

Chitosan Nanoparticles Strengthen Vγ9Vδ2 T-Cell Cytotoxicity Through Upregulation Of Killing Molecules And Cytoskeleton Polarization
por: Lin, Li, et al.
Publicado: (2019)

A generic RNA-pulsed dendritic cell vaccine strategy for renal cell carcinoma
por: Geiger, Christiane, et al.
Publicado: (2005)

Vδ2 T-Cells Kill ZIKV-Infected Cells by NKG2D-Mediated Cytotoxicity
por: Cimini, Eleonora, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_3dis2pskpcv1bpvjth3lg358ta